Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Colitis Ulcerative

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Colitis Ulcerative:

Pubmed Logo
[Diagnostic guideline of ulcerative colitis]
Ulcerative colitis is a chronic inflammatory disorder causing mucosal...
13th November, 2009
Department of Internal Medicine, Chung-Ang University College of Medicine, Korean J Gastroenterol. 2009 Mar;53(3):145-60.
Severe rosacea in a patient on infliximab for ulcerative colitis: pathophysiological considerations.
The introduction of TNF-alpha blocking therapy has produced a dramatic...
13th November, 2009
Acta Derm Venereol. 2009;89(5):522-3.
DOI Direct Link
Clinical relevance of circulating midkine in ulcerative colitis.
BACKGROUND: Non-invasive biochemical markers are needed to support the...
13th November, 2009
Department of Medical Biochemistry, Wroclaw Medical University, Wroclaw, Clin Chem Lab Med. 2009;47(9):1085-90.
DOI Direct Link
[Extraintestinal manifestations in inflammatory bowel disease]
Extraintestinal manifestations are relatively common in chronic...
3rd November, 2009
c/o Ole Haagen Nielsen, Gastroenheden, Medicinsk Sektion, Herlev Hospital, Ugeskr Laeger. 2009 Oct 19;171(43):3078-83.
[TNF-alpha blocking therapy in chronic inflammatory bowel disease]
The introduction of TNF-alpha blocking therapy has produced a dramatic...
31st October, 2009
Szegedi Tudomanyegyetem, Altalanos Orvostudomanyi Kar, I. Belgyogyaszati Orv Hetil. 2009 Sep 20;150(38):1773-9.
DOI Direct Link

View more research publications.

Press Releases About Colitis Ulcerative:

BioPortfolio Logo
Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference 12th November, 2009 Hollis-Eden Pharmaceuticals, Inc.
SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH), will present results of its ongoing human clinical Phase I/II open-label dose-ranging trial with Apoptone
Shire Continues to Deliver Excellent Growth From Core Products 30th October, 2009
DUBLIN, October 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009. Q3 2009
Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting 26th October, 2009 Shire plc
SAN DIEGO, Oct. 26 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented the results of three 5-aminosalicylic acid (5-ASA)
The Great Comebacks(R) Program Announces 2009 Regional Awards Recipients 1st October, 2009 ConvaTec
-- West: Sylvia Prothro Hebert, 42, Park City, UT "These debilitating diseases, and the prospect of ostomy surgery, can leave you feeling isolated, fearful and uncertain about the future,
Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 1st October, 2009 Mayo Clinic
ROCHESTER, Minn., Oct. 1 /PRNewswire-USNewswire/ -- A new study led by Mayo Clinic researchers has found that ulcerative colitis patients had a 41 percent reduction in colectomy after a year when

BioNews Results for Colitis Ulcerative:

RSS Logo
BioPortfolio Logo
A Study of Abatacept in Patients With Active Ulcerative Colitis
SmartBrief:  Nov 11 2009 1:13AM Matching: colitis ulcerative
Joint Extraintestinal Manifestations in Ulcerative Colitis
MDLinx:  Nov 9 2009 2:44PM Matching: colitis ulcerative
Medical Management of Ulcerative Colitis
MDLinx:  Nov 9 2009 11:55AM Matching: colitis ulcerative
Hutchison China MediTech Limited ('Chi-Med') - Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-0
Pharma Live:  Nov 5 2009 11:15PM Matching: colitis ulcerative
Adalimumab Initially Effective in Infliximab-Resistant Ulcerative Colitis, But Effects Are Not Durable
Abstracts in Hematology and Oncology:  Nov 2 2009 2:28PM Matching: colitis ulcerative
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Colitis Ulcerative Clinical Trials:

Clinical Trials Logo
Metabolic Response to Infliximab in Pediatric Ulcerative Colitis

Colitis Ulcerative Patents:

USPTO Logo
US Patent No.Title
7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
7276511 Benzylamine derivative
7311666 Apparatus for collecting information
7335676 Methods for treating inflammatory conditions or inhibiting JNK
7345178 Sirtuin modulating compounds

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Colitis Ulcerative scientists - we have details of around 2140 individuals working on Colitis Ulcerative .


This page has been viewed 286 times
Recent Search Terms used to find this page: ulcerative colitis | Reflections on the future of gastroenterology--unmet needs. | hollis eden colitis salofalk | ulcerative colitis sarcoidosis | Evidence-based medicine or hocuspocus | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Colitis Ulcerative across BioPortfolio, or for Colitis Ulcerative Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.